Widening the Therapeutic Window in The Management of Parkinson’s Disease


Expert neurologists discuss strategies to widen the therapeutic window of Parkinson’s disease and options available to treat dyskinesia, providing better control of Parkinson’s disease.


1:20 Long-term challenges

2:58 Fluctuations in benefits

6:35 Therapeutic window

11:40 Amantadine ER for PD

14:33 Dyskinesia and treatment

18:18 Amantadine patients

23:14 Amantadine formulations

27:59 Early treatment & future

Related Videos
Ray Dorsey, MD
© 2024 MJH Life Sciences

All rights reserved.